mk 6240
Small moleculeexperimental
Clinical trial activity
14 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
7
Phase 3
2
Phase 4
0
Earliest trial started Oct 19, 2015 (NCT02562989)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk-6240
- mk-6240
- mni-946
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06600880 | Phase 1 | Oct 1, 2024 | Columbia University |
| NCT06860373 | Phase 3 | Jun 27, 2023 | LuMind IDSC Foundation |
| NCT05361382 | Phase 1 | Nov 23, 2021 | National Institute on Aging (NIA), University of Pittsburgh |
| NCT04784416 | Phase 2 | Apr 27, 2021 | Alzheimer's Association, Harvard University, LiteCure LLC, National Institutes of Health (NIH), New York University |
| NCT04576793 | Phase 2 | Nov 1, 2020 | Columbia University, National Institute on Aging (NIA) |
| NCT03757910 | Early Phase 1 (Phase 1) | Jul 31, 2019 | Columbia University, George Washington University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Yeshiva University |
| NCT04104659 | Phase 2 | Apr 11, 2019 | Washington University in St. Louis |
| NCT03919669 | Phase 2 | Apr 1, 2019 | Cerveau Technologies, Inc., University of Wisconsin |
| NCT03706261 | Phase 1 | Mar 22, 2019 | Columbia University, National Institute on Aging (NIA) |
| NCT03860857 | Phase 3 | May 1, 2018 | National Institute on Aging (NIA), University of California, Irvine |
| NCT03514524 | N/A | Feb 1, 2018 | Katholieke Universiteit Leuven |
| NCT03373604 | Phase 2 | Dec 11, 2017 | Columbia University, National Institute on Aging (NIA) |
| NCT03071224 | Early Phase 1 (Phase 1) | Jun 1, 2016 | Molecular NeuroImaging |
| NCT02562989 | Phase 1 | Oct 19, 2015 | Merck |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (19)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 5 | 5 | 2 | 2017 |
| National Institute on Aging (NIA) | Government | 5 | 0 | 3 | 2017 |
| Alzheimer's Association | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Cerveau Technologies, Inc. | For profit | 1 | 0 | 1 | 2019 |
| George Washington University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 1 | 1 | 2018 |
| LiteCure LLC | For profit | 1 | 0 | 1 | 2021 |
| LuMind IDSC Foundation | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Merck | For profit | 1 | 1 | 1 | 2015 |
| Molecular NeuroImaging | For profit | 1 | 1 | 1 | 2016 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2019 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2021 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of California, Irvine | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Wisconsin | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2019 |
19 organizations
Page 1 / 1